LOADING
Comparing Merck & Company (MRK) and Coinbase Global (COIN) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | COIN |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $283.3B | $45.8B |
| P/E Ratio | 32.2 | 64.2 |
| Forward P/E | 22.8 | 79.4 |
| PEG Ratio | 5.38 | 1.01 |
| EPS | $3.56 | $2.71 |
| Revenue Growth (YoY) | 4.9% | -30.8% |
| Profit Margin | 13.6% | 12.7% |
| Return on Equity | 18.9% | 6.7% |
| Dividend Yield | 2.84% | -- |
| Beta | 0.20 | 3.38 |
| 52-Week High | $124.22 | $444.64 |
| 52-Week Low | $74.71 | $139.36 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.